Business Wire

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development

Share

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture.

The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts.

The service is adapted to the stage of development and the properties of the molecule and provided on a dedicated FTE basis, ensuring flexibility and depth of exposure to the lead candidates. Customers can then seamlessly transition the program into cell line development using Abzena’s proprietary cell line.

Dr Campbell Bunce, Abzena’s SVP of Scientific Operations and Cambridge UK site head commented: “Abzena is excited to combine solutions where we have deep expertise and resource into a single low-cost Developability Service. Our customers rely on our ability to significantly shorten timelines, derisk lead optimization and improve clinical outcomes. Our Developability Service is provided on an FTE basis and typically requires only a few months per project to evaluate several drug candidates. We are delighted to add this service to our existing integrated discovery, cell line development, process development and biologics GMP manufacturing capabilities.”

Dr. Jonathan Goldman MD, Abzena CEO added: Abzena is the only PRO dedicated to target to GMP for large molecules, ADCs and complex small molecules. We are delighted to announce this expansion of our integrated capabilities. Our goal is to assist customers in translating complex scientific concepts to safe and effective clinical products and rapidly bring these to patients in need.”

--

About Abzena

Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is partnered with Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.

Abzena’s Developability assessment runs parallel to the drug development pathway with high-throughput in silico analysis of drug candidates following antibody discovery, moving to comprehensive physical property, formulation, in vitro and in vivo assessments allowing shortlisting of candidates for cell line development and manufacture.

Contact information

Abzena
Joseph Reeds
joseph.reeds@abzena.com
+44 1223 903367

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Acrisure and Tulco Unveil Altway Insurance19.9.2019 16:00:00 CESTPress release

Top 10 global insurance broker Acrisure and leading investment company Tulco Holdings unveils Altway Insurance, a direct-to-consumer brokerage platform which is fully supported by artificial intelligence. Altway Insurance represents a unique blend of a world-class AI firm matched with an insurance broker with an equally world-class distribution network. Additionally, Google Cloud is working closely with the company on how to integrate Google's most cutting-edge AI technology into new AI applications. Tulco Chairman and CEO Thomas Tull said, “While there has been substantial investment to fuse technology and insurance, today, there remains a massive and unmet opportunity to truly create the broker of the future. To meet that opportunity, we're thrilled to combine the AI and analytics leadership of Tulco with the phenomenal growth and global distribution power of Acrisure.” Underlying Altway is the unique combination of Acrisure and Tulco. Acrisure delivers high quality insurance service

Mindbreeze recognized once again as a Leader in the 2019 Gartner Magic Quadrant for Insight Engines19.9.2019 15:20:00 CESTPress release

Mindbreeze, a leading global provider of appliances and cloud services for information insight and applied artificial intelligence with a focus on knowledge management for international companies, announced today that the company has been positioned by Gartner, Inc. as a Leader in the 2019 Magic Quadrant for Insight Engines. A complimentary copy of the report can be accessed from the Mindbreeze website “Mindbreeze enables our customers and their employees to garner and leverage crucial insights from their data. We work directly with our customers in this innovative field to bring meaning and value to their information assets that take us to the next level together,” comments Daniel Fallmann, Mindbreeze CEO and founder. “We believe this recognition further validates Mindbreeze’s success in the AI and knowledge management industry, as enterprises achieve ideal results using our unique and innovative solution.” Download the 2019 Magic Quadrant for Insight Engines now Many well-known custo

Amazon Co-founds The Climate Pledge, Setting Goal to Meet the Paris Agreement 10 Years Early19.9.2019 15:15:00 CESTPress release

Today, Amazon (NASDAQ: AMZN) and Global Optimism announced The Climate Pledge, a commitment to meet the Paris Agreement 10 years early. Amazon today becomes the first signatory of this pledge. The Climate Pledge calls on signatories to be net zero carbon across their businesses by 2040—a decade ahead of the Paris Accord’s goal of 2050. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190919005609/en/ Companies that sign The Climate Pledge agree to: Measure and report greenhouse gas emissions on a regular basis; Implement decarbonization strategies in line with the Paris Agreement through real business changes and innovations, including efficiency improvements, renewable energy, materials reductions, and other carbon emission elimination strategies; Neutralize any remaining emissions with additional, quantifiable, real, permanent, and socially-beneficial offsets to achieve net zero annual carbon emissions by 2040. “We’re done b

In Impact Investing First, LeapFrog Announces Audit on Impact Principles, Achieving Top Rating19.9.2019 15:02:00 CESTPress release

LeapFrog Investments today became the first impact investor globally to announce the results of an independent audit of its impact against the Operating Principles for Impact Management, new industry standards developed by the IFC in consultation with leading impact investors and other stakeholders. Launched in April, the Principles provide common disciplines for management of investments for impact, helping to ensure authenticity and high standards of measurement. In the independent audit by Tideline, a leading US impact advisory consultancy, LeapFrog was assessed as an “Exemplification of industry best practice,” with its Impact Measurement and Management (IMM) system achieving “an advanced level of alignment across the board for all nine of the Principles.” Tideline concluded that “LeapFrog’s IMM comprehensively addresses and exceeds the implementation guidance provided by the IFC and has been refined and strengthened over the course of several funds.” “The impact investing industry

Andersen Global Expands Reach in London19.9.2019 13:30:00 CESTPress release

Andersen Global continues its expansion in the UK as Miles Dean, Zoe Wyatt and their team join the Andersen Tax LLP team in the UK. This addition brings further depth to the group in London and enhances the team’s ability to work with clients holistically and provide best-in-class, seamless service. Andersen Global has a presence in five locations in the UK through its member and collaborating firms. Miles and Zoe previously worked at Milestone which was founded by Miles Dean in 2008, with Zoe Wyatt joining as a partner in 2015. As part of Andersen Tax LLP, these partners will continue to provide a broad range of international tax services to corporations and private clients, investment funds and real estate investors and developers. Milestone signed a collaboration agreement with Andersen Global in 2018 and the positive impact of this relationship has led to Miles, Zoe and their team now joining the Andersen Global member firm in the UK. “It was so important to us to ensure we are pos

CGLytics and Glass Lewis Set a New Standard for Transparency in Equity-based Compensation19.9.2019 13:15:00 CESTPress release

CGLytics, a leading global provider of governance data and analytics, and Glass Lewis, the world’s leading independent provider of governance and engagement support services, today announced the launch of Glass Lewis’ Equity Compensation Model (ECM) - a powerful new application for assessing U.S. equity-based compensation plans, available exclusively via CGLytics. This new application provides invaluable intelligence with year-round, on-demand access to Glass Lewis’ methodology which is used to evaluate the overall favorability of current and future equity plans, including tests against 11 key criteria. Companies and investors can now instantly test, review and adjust the same individual inputs as Glass Lewis’ analysts to ensure the best compensation, engagement and voting outcomes for their respective sides. The ECM provides companies with immediate and proactive insight into the concerns regarding current and future equity plans, which Glass Lewis highlights to more than 1,300 invest